ATORVASTATINE ARROW GENERIQUES 20 mg, film-coated tablet 30 tablets, CIP 3400930035436
Active ingredients: Atorvastatin, Atorvastatin calcium trihydrate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet30 tablets, CIP 3400930035436orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ATORVASTATINE ARROW GENERIQUES 20 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- flacon(s) polyéthylène haute densité (PEHD) de 30 comprimé(s)
- Marketing authorisation holder
- ARROW GENERIQUES
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Jan 2018
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69068936CIP73003543CIP133400930035436Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ATORVASTATINEcomprimé | 20 mg · un comprimé | FT |
| ATORVASTATINE CALCIQUE TRIHYDRATÉEcomprimé | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.